For example, blocking MMP activation or MMP-9 knock-out (KO) prevented degradation of CLN-5 and OCLN, and attenuated BBB disruption, in cerebral ischemia/reperfusion animal models [52,53]. The gene discussed is CLN5; the disease is brain ischemia.